Colchicina como tratamiento del síndrome de fiebre periódica, estomatitis aftosa, faringitis y adenitis cervical pediátrico (PFAPA)

un estudio de caso

Palabras clave: fiebre, estomatitis, faringitis, linfadenitis, colchicina

Resumen

El síndrome fiebre periódica, estomatitis aftosa, faringitis y adenitis cervical (PFAPA) es un tipo frecuente de fiebre recurrente en infantes. Entre las opciones de tratamiento se encuentran: antiinflamatorios no esteroideos, cimetidina, esteroides, colchicina y la amigdalectomía. La colchicina funciona como un modulador del sistema inmunológico, sin producir inmunosupresión, y es el tratamiento profiláctico de elección en el PFAPA, disminuyendo la duración e intensidad de las crisis febriles y aumentando el intervalo entre episodios.  

Estadistica de descarga del artículo

Cargando métricas ...

Biografía del autor/a

Dra. Karolina González Houdelath, Investigadora independiente, San José, Costa Rica

Médica general, graduada de la Universidad de Costa Rica (UCR). cod. MED15826.  Correo: kgh_cr@hotmail.com

Dra. Ana Cristina Varela Moreno, Investigadora independiente, San José, Costa Rica

Médica general, graduada de la Universidad de Costa Rica (UCR). cod. MED15848. Correo: cvarelam28@gmail.com

Dr. Gerald Josué Barrantes Astorga, Investigador independiente, San José, Costa Rica

Médico general, graduado de la Universidad de Costa Rica (UCR) . cod. MED15899. Correo: geraldba93@gmail.com

Citas

Ali N, Sartori-Valinotti J, Bruce A. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome. Clinics in Dermatology. 2016; 34(4): 482-486. https://doi.org/10.1016/j.clindermatol.2016.02.021

Vanoni F, Theodoropoulou K, Hofer M. PFAPA syndrome: a review on treatment and outcome. Pediatric Rheumatology. 2016; 14(1). https://doi.org/10.1186/s12969-016-0101-9

Theodoropoulou K, Vanoni F, Hofer M. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome: a Review of the Pathogenesis. Current Rheumatology Reports. 2016; 18(4). https://doi.org/10.1007/s11926-016-0567-y

Wekell P. Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis síndrome - PFAPA syndrome. La Presse Médicale. 2019; 48(1): 77-87. https://doi.org/10.1016/j.lpm.2018.08.016

Batu E. Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: main features and an algorithm for clinical practice. Rheumatology International. 2019; 39(6): 957-970. https://doi.org/10.1007/s00296-019-04257-0

Tejesvi M, Uhari M, Tapiainen T, Pirttilä A, Suokas M, Lantto U et al. Tonsillar microbiota in children with PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome. European Journal of Clinical Microbiology & Infectious Diseases. 2016; 35(6): 963-970. https://doi.org/10.1007/s10096-016-2623-y

Kraszewska-Głomba B, Matkowska-Kocjan A, Szenborn L. The Pathogenesis of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome: A Review of Current Research. Mediators of Inflammation. 2015. https://doi.org/10.1155/2015/563876

Kettunen S, Lantto U, Koivunen P, Tapiainen T, Uhari M, Renko M. Risk factors for periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a case-control study. European Journal of Pediatrics. 2018; 177(8): 1201-1206. https://doi.org/10.1007/s00431-018-3175-1

Nalbantoğlu A, Nalbantoğlu B. Vitamin D deficiency as a risk factor for PFAPA syndrome. International Journal of Pediatric Otorhinolaryngology. 2019; 121: 55-57. https://doi.org/10.1016/j.ijporl.2019.02.047

Perko D, Debeljak M, Toplak N, Avčin T. Clinical Features and Genetic Background of the Periodic Fever Syndrome with Aphthous Stomatitis, Pharyngitis, and Adenitis: A Single Center Longitudinal Study of 81 Patients. Mediators of Inflammation. 2015. https://doi.org/10.1155/2015/293417

Gaggiano C, Rigante D, Sota J, Grosso S, Cantarini L. Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review. Clinical Rheumatology. 2018; 38(1): 11-17. https://doi.org/10.1007/s10067-018-4361-2

Więsik-Szewczyk E, Wolska-Kuśnierz B, Jahnz-Różyk K. Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome persisting to adulthood - an example of a diagnostic and therapeutic challenge. Reumatologia/Rheumatology. 2019; 57(5): 292-296. https://doi.org/10.5114/reum.2019.89523

Angelidis C, Kotsialou Z, Kossyvakis C, Vrettou A, Zacharoulis A, Kolokathis F et al. Colchicine Pharmacokinetics and Mechanism of Action. Curr Pharm Des. 2018; 24(6): 659-663. https://doi.org/10.2174/1381612824666180123110042

Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett D. Colchicine: an ancient drug with novel applications. British Journal of Dermatology. 2018; 178: 350-356. https://doi.org/10.1111/bjd.15896

Katz J, Langevitz P, Shemer J, Barak S, Livneh A. Prevention of recurrent aphthous stomatitis with colchicine: An open trial. J Am Acad Dermatol. 1994; 31: 459-461. https://doi.org/10.1016/S0190-9622(94)70211-X

Butbul-Aviel Y, Tatour S, Gershoni Baruch R, Brik R. Colchicine as a therapeutic option in periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome. Seminars in Arthritis and Rheumatism. 2016; 45(4): 471-474. https://doi.org/10.1016/j.semarthrit.2015.07.005

Slobodnick A, Shah B, Krasnokutsky S, Pillinger M. Update on colchicine. Rheumatology. 2017; 57(1): 4-11. https://doi.org/10.1093/rheumatology/kex453

Dubey K, Kumar P, Labrou N, Shukla P. Biotherapeutic potential and mechanisms of action of colchicine. Critical Reviews in Biotechnology. 2017; 37(8): 1038-1047.https://doi.org/10.1080/07388551.2017.1303804

Abbott C, Xu R, Sigal S. Colchicine-Induced Hepatotoxicity. ACG Case Reports Journal. 2017; 4: 120-123. https://doi.org/10.14309/crj.2017.120

Ben-Chetrit E. Colchicine. Textbook of Autoinflammation. 2019.

https://doi.org/10.1007/978-3-319-98605-0_40

Bueno L, Paiva D, Carvalho P. Síndrome PFAPA: Diagnóstico e Tratamento na Atenção Primária à Saúde. Revista Brasileira de Medicina de Família e Comunidade. 2019; 14(41).

https://doi.org/10.5712/rbmfc14(41)1815

Cabras M, Carrozzo M, Gambino A, Broccoletti R, Sciascia S, Baldovino S et al. Value of colchicine as treatment for recurrent oral ulcers: A systematic review. Journal of Oral Pathology & Medicine. 2020. https://doi.org/10.1111/jop.13020

Manthiram K, Li S, Hausmann J, Amarilyo G, Barron K, Kim H et al. Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. Rheumatology International. 2017; 37(6): 883-889. https://doi.org/10.1007/s00296-017-3688-3

Vanoni F, Theodoropoulou K, Hofer M. PFAPA syndrome: a review on treatment and outcome. Pediatric Rheumatology. 2016; 14(1). https://doi.org/10.1186/s12969-016-0101-9

Dusser P, Hentgen V, Neven B, Koné-Paut I. Is colchicine an effective treatment in periodic fever, aphtous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome?. Joint Bone Spine. 2016; 83(4): 406-411. https://doi.org/10.1016/j.jbspin.2015.08.017

Gunes M, Cekic S, Kilic S. Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?. Pediatrics International. 2017; 59(6): 655-660. https://doi.org/10.1111/ped.13265

Hausmann J, Guven B, Anderson E, Dedeoglu F. Predicting Colchicine Response In Patients With Undefined Autoinflammatory Diseases. Arthritis Rheumatol. 2017; 69 (4).

Papa R, Rusmini M, Volpi S, Caorsi R, Picco P, Grossi A et al. Next generation sequencing panel in undifferentiated autoinflammatory diseases identify patients with colchicine-responder recurrent fevers. Rheumatology. 2020; 59(2): 344-360. https://doi.org/10.1093/rheumatology/kez270

Ozen S, Kone-Paut I, Gül A. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments. Seminars in Arthritis and Rheumatism. 2017; 47: 115-120. https://doi.org/10.1016/j.semarthrit.2017.03.006

Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S et al. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis & Rheumatology. 2017; 69(4): 854-862.https://doi.org/10.1002/art.39995

Grimwood C, Kone-Paut I, Piram M, Rossi-Semerano L, Hentgen V. Health-related quality of life in children with PFAPA syndrome. Orphanet Journal of Rare Diseases. 2018; 13(1). https://doi.org/10.1186/s13023-018-0878-3

Kadhim C, Maiolini F, Cerrito L, Sicignano L, Giovinale M, Verrecchia E et al. Colchicine trial in PFAPA Syndrome and MEFV-negative patients. Pediatric Rheumatology. 2015; 13(1). https://doi.org/10.1186/1546-0096-13-S1-O5

Batu E, Batu H. Recurrence of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome after tonsillectomy: case-based review. Rheumatology International. 2019; 39(6): 1099-1105. https://doi.org/10.1007/s00296-019-04310-y

Publicado
2020-09-01
Cómo citar
1.
González Houdelath K, Varela Moreno AC, Barrantes Astorga GJ. Colchicina como tratamiento del síndrome de fiebre periódica, estomatitis aftosa, faringitis y adenitis cervical pediátrico (PFAPA). Rev.méd.sinerg. [Internet]. 1 de septiembre de 2020 [citado 2 de diciembre de 2020];5(9):e580. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/580
Sección
Reporte de Casos Clinicos

Artículos más leídos del mismo autor/a